World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
14120
World Ranking
2623
National Ranking
27

Carlos López-Larrea publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Carlos López-Larrea sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 252 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Carlos López-Larrea D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Carlos López-Larrea sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Carlos López-Larrea is affiliated with the Central University Hospital of Asturias in Spain. Their research primarily spans the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a notable focus on Infectious Diseases, Immunology, and Molecular Biology as significant subfields.

The scientist has contributed extensively to research topics related to COVID-19 Clinical Research Studies and SARS-CoV-2 and COVID-19 Research. Other main topics in their work include the Complement system in diseases, Protein Degradation and Inhibitors, Autophagy in Disease and Therapy, Endoplasmic Reticulum Stress and Disease, and Multiple Myeloma Research and Treatments.

Frequent publication venues for their work include:

  • Nephrology Dialysis Transplantation
  • Preprints.org
  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • International Journal of Molecular Sciences

Carlos López-Larrea has collaborated frequently with several coauthors, including:

  • Beatriz Suárez-Álvarez
  • María Laura Sáiz
  • Marta Ruiz-Ortega
  • Viviana Corte-Iglesias
  • Raúl R. Rodrigues-Díez

Among recent publications, notable papers include:

  • "Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome," 2020, Gene
  • "Crosstalk Between Hypoxia and ER Stress Response: A Key Regulator of Macrophage Polarization," 2020, Frontiers in Immunology
  • "The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19," 2020, Cytokine
  • "Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity," 2021, Clinical Epigenetics
  • "Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity," 2021, International Immunopharmacology

Best Publications

  • Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    D M Evans;Spencer Cca.;J J Pointon;Z Su

  • Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.

    A Cortes;J Hadler;J P Pointon

  • The Inflammatory Cytokines TWEAK and TNFα Reduce Renal Klotho Expression through NFκB

    Juan A. Moreno;Maria C. Izquierdo;Maria D. Sanchez-Niño;Beatriz Suárez-Alvarez

  • Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    D.M. Evans;C.C.A. Spencer;J.J. Pointon;Z. Su

  • Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.

    Adrian Cortes;Sara L. Pulit;Paul J. Leo;Jenny J. Pointon

  • NKG2D ligands: key targets of the immune response

    Segundo González;Alejandro López-Soto;Beatriz Suarez-Alvarez;Antonio López-Vázquez

  • HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis

    S. Gonzalez-Roces;M. V. Alvarez;S. Gonzalez;A. Dieye

  • When Aging Reaches CD4+ T-Cells: Phenotypic and Functional Changes

    Marco Antonio Moro-García;Rebeca Alonso-Arias;Carlos Lopez-Larrea

  • Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.

    Juan Gómez;Guillermo M. Albaiceta;Marta García-Clemente;Carlos López-Larrea

  • The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis.

    Segundo Gonzalez;J. Martinez‐Borra;J. C. Torre‐Alonso;S. Gonzalez‐Roces

  • Sirtuin 1 regulation of developmental genes during differentiation of stem cells

    Vincenzo Calvanese;Ester Lara;Beatriz Suárez-Álvarez;Raed Abu Dawud

  • Protective Effect of the HLA-Bw4I80 Epitope and the Killer Cell Immunoglobulin-Like Receptor 3DS1 Gene against the Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection

    Antonio López-Vázquez;Luis Rodrigo;Jesús Martínez-Borra;Ramón Pérez

  • TNF-α −308A promoter polymorphism is associated with enhanced TNF-α production and inflammatory activity in Crohn’s patients with fistulizing disease

    Segundo González;Luis Rodrigo;Jesús Martínez-Borra;Antonio López-Vázquez

  • DNA methylation: a promising landscape for immune system-related diseases.

    Beatriz Suarez-Alvarez;Ramon M. Rodriguez;Mario F. Fraga;Carlos López-Larrea

  • The NKG2D receptor: sensing stressed cells.

    Carlos López-Larrea;Beatriz Suárez-Alvarez;Alejandro López-Soto;Antonio López-Vázquez

  • Crosstalk Between Hypoxia and ER Stress Response: A Key Regulator of Macrophage Polarization.

    Paula Díaz-Bulnes;María Laura Saiz;Carlos López-Larrea;Ramón M. Rodríguez

  • High serum tumor necrosis factor-α levels are associated with lack of response to infliximab in fistulizing Crohn’s disease

    Jesús Martínez-Borra;Carlos López-Larrea;Segundo González;Dolores Fuentes

  • Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects

    Marco Antonio Moro-García;Rebeca Alonso-Arias;Maria Baltadjieva;Carlos Fernández Benítez

  • The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection.

    B. Suárez-Álvarez;A. López-Vázquez;M. Zapico Gonzalez;J. L. Fdez-Morera

  • MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201

    A Lopez-Vazquez;L Rodrigo;D Fuentes;S Riestra

  • Mobilization and homing of hematopoietic stem cells.

    Beatriz Suárez-Álvarez;Antonio López-Vázquez;Carlos López-Larrea

  • Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population.

    Segundo González;Chaim Brautbar;J Martı́nez-Borra;A López-Vazquez

  • Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

    A. Cortes;J. Hadler;J.P. Pointon;P.C. Robinson

Frequent Co-Authors

Segundo González
Segundo González University of Oviedo
Eliecer Coto
Eliecer Coto University of Oviedo
Victoria Alvarez
Victoria Alvarez University of Oviedo
Marta Ruiz-Ortega
Marta Ruiz-Ortega Autonomous University of Madrid
Mario F. Fraga
Mario F. Fraga University of Oviedo
Francisco Ortega
Francisco Ortega Institució Catalana de Recerca i Estudis Avançats
Alberto Ortiz
Alberto Ortiz Autonomous University of Madrid
Agustín F. Fernández
Agustín F. Fernández University of Oviedo
Jesús Egido
Jesús Egido Autonomous University of Madrid
David Evans
David Evans University of Bristol

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can broaden career opportunities in research, patient care, and specialized clinical roles. Many professionals start with foundational nursing programs before advancing into more focused fields, such as immunology research or clinical immunology practice.

Non-nurses looking to enter healthcare quickly often consider programs like the best online RN programs for non nurses, which offer flexible pathways to becoming a registered nurse. Once licensed, some may opt for accelerated options like ABSN programs with high acceptance rates to enhance their clinical skills efficiently.

Advanced practice nurses can specialize further by enrolling in accelerated NP programs online, allowing for accelerated transition into nurse practitioner roles. Specifically, those aiming to work in acute settings related to immunology research or care might pursue an FNP to acute care certification, which facilitates specialization in managing complex patients with immune system disorders.

Overall, exploring these pathways alongside Immunology studies can open doors to rewarding careers bridging scientific research and patient-centered healthcare.

Best Scientists Citing Carlos López-Larrea

Trending Scientists

Recently Published Articles